{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:47:04Z","timestamp":1785862024753,"version":"3.56.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> To establish and validate a nomogram integrating radiomics signatures from ultrasound and clinical factors to discriminate between benign, borderline, and malignant serous ovarian tumors.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> In this study, a total of 279 pathology-confirmed serous ovarian tumors collected from 265 patients between March 2013 and December 2016 were used. The training cohort was generated by randomly selecting 70% of each of the three types (benign, borderline, and malignant) of tumors, while the remaining 30% was included in the validation cohort. From the transabdominal ultrasound scanning of ovarian tumors, the radiomics features were extracted, and a score was calculated. The ability of radiomics to differentiate between the grades of ovarian tumors was tested by comparing benign vs borderline and malignant (task 1) and borderline vs malignant (task 2). These results were compared with the diagnostic performance and subjective assessment by junior and senior sonographers. Finally, a clinical-feature alone model and a combined clinical-radiomics (CCR) model were built using predictive nomograms for the two tasks. Receiver operating characteristic (ROC) analysis, calibration curve, and decision curve analysis (DCA) were performed to evaluate the model performance.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The US-based radiomics models performed satisfactorily in both the tasks, showing especially higher accuracy in the second task by successfully discriminating borderline and malignant ovarian serous tumors compared to the evaluations by senior sonographers (AUC = 0.789 for seniors and 0.877 for radiomics models in task one; AUC = 0.612 for senior and 0.839 for radiomics model in task 2). We showed that the CCR model, comprising CA125 level, lesion location, ascites, and radiomics signatures, performed the best (AUC = 0.937, 95%CI 0.905\u20130.969 in task 1, AUC = 0.924, 95%CI 0.876\u20130.971 in task 2) in the training as well as in the validation cohorts (AUC = 0.914, 95%CI 0.851\u20130.976 in task 1, AUC = 0.890, 95%CI 0.794\u20130.987 in task 2). The calibration curve and DCA analysis of the CCR model more accurately predicted the classification of the tumors than the clinical features alone.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study integrates novel radiomics signatures from ultrasound and clinical factors to create a nomogram to provide preoperative diagnostic information for differentiating between benign, borderline, and malignant ovarian serous tumors, thereby reducing unnecessary and risky biopsies and surgeries.<\/jats:p>","DOI":"10.3389\/fgene.2021.753948","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:59:16Z","timestamp":1632805156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors"],"prefix":"10.3389","volume":"12","author":[{"given":"Lisha","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of Ovarian Cancer: a Review","volume":"14","author":"Brett","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40477-020-00503-5","article-title":"The Adoption of Radiomics and Machine Learning Improves the Diagnostic Processes of Women with Ovarian MAsses (The AROMA Pilot Study)","author":"Chiappa","year":"2020","journal-title":"J. Ultrasound"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/uog.23530","article-title":"Ultrasound Image Analysis Using Deep Neural Networks for Discriminating between Benign and Malignant Ovarian Tumors: Comparison with Expert Subjective Assessment","volume":"57","author":"Christiansen","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1097\/PAS.0000000000001325","article-title":"Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma","volume":"43","author":"Chui","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ijgo.12970","article-title":"Diagnostic Value of the International Ovarian Tumor Analysis ( IOTA ) Simple Rules versus Pattern Recognition to Differentiate between Malignant and Benign Ovarian Masses","volume":"147","author":"Dakhly","year":"2019","journal-title":"Int. J. Gynecol. Obstet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/uog.17392","article-title":"Clinical and Ultrasound Characteristics of Surgically Removed Adnexal Lesions with Largest Diameter \u2264 2.5 Cm: a Pictorial Essay","volume":"50","author":"Di Legge","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdw090","article-title":"Management of Borderline Ovarian Tumors","volume":"27","author":"du Bois","year":"2016","journal-title":"Ann. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The Untapped Potential of Ascites in Ovarian Cancer Research and Treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","article-title":"Management of Borderline Ovarian Tumours","volume":"41","author":"Gershenson","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2214\/AJR.15.15199","article-title":"Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging","volume":"206","author":"Javadi","year":"2016","journal-title":"Am. J. Roentgenology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/s0140-6736(13)62146-7","article-title":"Ovarian Cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"The Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00330-020-07091-2","article-title":"MR Image-Based Radiomics to Differentiate Type \u0399 and Type \u0399\u0399 Epithelial Ovarian Cancers","volume":"31","author":"Jian","year":"2021","journal-title":"Eur. Radiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","article-title":"Radiomics Signature of Computed Tomography Imaging for Prediction of Survival and Chemotherapeutic Benefits in Gastric Cancer","volume":"36","author":"Jiang","year":"2018","journal-title":"EBioMedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of Epithelial Ovarian Cancer","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial Ovarian Cancer: Evolution of Management in the Era of Precision Medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA A. Cancer J. Clin."},{"key":"B17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Ijms"},{"key":"B18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41467-019-08718-9","article-title":"A Mathematical-Descriptor of Tumor-Mesoscopic-Structure from Computed-Tomography Images Annotates Prognostic- and Molecular-Phenotypes of Epithelial Ovarian Cancer","volume":"10","author":"Lu","year":"2019","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"BSR20190656","DOI":"10.1042\/BSR20190656","article-title":"Expression of RRBP1 in Epithelial Ovarian Cancer and its Clinical Significance","volume":"39","author":"Ma","year":"2019","journal-title":"Biosci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian Cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to Radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J. Nucl. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/uog.17414","article-title":"Imaging in Gynecological Disease (12): Clinical and Ultrasound Features of Invasive and Non-invasive Malignant Serous Ovarian Tumors","volume":"50","author":"Moro","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fonc.2020.00895","article-title":"A Nomogram Combined Radiomic and Semantic Features as Imaging Biomarker for Classification of Ovarian Cystadenomas","volume":"10","author":"Pan","year":"2020","journal-title":"Front. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1007\/s00330-020-06993-5","article-title":"MR Imaging of Epithelial Ovarian Cancer: a Combined Model to Predict Histologic Subtypes","volume":"30","author":"Qian","year":"2020","journal-title":"Eur. Radiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1007\/s00330-018-5389-z","article-title":"Radiomics of High-Grade Serous Ovarian Cancer: Association between Quantitative CT Features, Residual Tumour and Disease Progression within 12 Months","volume":"28","author":"Rizzo","year":"2018","journal-title":"Eur. Radiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00330-020-07112-0","article-title":"Radiomics Derived from Dynamic Contrast-Enhanced MRI Pharmacokinetic Protocol Features: the Value of Precision Diagnosis Ovarian Neoplasms","volume":"31","author":"Song","year":"2020","journal-title":"Eur. Radiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/uog.20283","article-title":"New Sonographic Marker of Borderline Ovarian Tumor: Microcystic Pattern of Papillae and Solid Components","volume":"54","author":"Timor\u2010Tritsch","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000265012","article-title":"Ultrasound Experience Substantially Impacts on Diagnostic Performance and Confidence when Adnexal Masses Are Classified Using Pattern Recognition","volume":"69","author":"Van Holsbeke","year":"2010","journal-title":"Gynecol. Obstet. Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/cancers12113403","article-title":"Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma","volume":"12","author":"Veeraraghavan","year":"2020","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/uog.20277","article-title":"Imaging in Gynecological Disease (16): Clinical and Ultrasound Characteristics of Serous Cystadenofibromas in Adnexa","volume":"54","author":"Virgilio","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1007\/s00261-021-03163-z","article-title":"Ultrasound-based Radiomics Score: a Potential Biomarker for the Prediction of Progression-free Survival in Ovarian Epithelial Cancer","volume":"46","author":"Yao","year":"2021","journal-title":"Abdom. Radiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","article-title":"Magnetic Resonance Imaging Radiomics in Categorizing Ovarian Masses and Predicting Clinical Outcome: a Preliminary Study","volume":"29","author":"Zhang","year":"2019","journal-title":"Eur. Radiol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.753948\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:59:19Z","timestamp":1632805159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.753948\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":32,"alternative-id":["10.3389\/fgene.2021.753948"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.753948","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"article-number":"753948"}}